{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T19:56:20Z","timestamp":1792007780992,"version":"4.4.0"},"reference-count":60,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1097\/cld.0000000000000216","type":"journal-article","created":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T18:00:30Z","timestamp":1717178430000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":15,"title":["Understanding fatigue and pruritus in primary biliary cholangitis"],"prefix":"10.1097","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-5957-2745","authenticated-orcid":false,"given":"Asma","family":"Faisal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,1]]},"reference":[{"key":"R1-20241015","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1136\/gutjnl-2017-315259","article-title":"The British Society of Gastroenterology\/UK-PBC primary biliary cholangitis treatment and management guidelines","volume":"67","author":"Hirschfield","year":"2018","journal-title":"Gut"},{"key":"R2-20241015","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1007\/s10620-019-5457-5","article-title":"Treatment of fatigue in primary biliary cholangitis: A systematic review and meta-analysis","volume":"64","author":"Lee","year":"2019","journal-title":"Dig Dis Sci"},{"key":"R3-20241015","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/S0140-6736(15)00154-3","article-title":"Primary biliary cirrhosis","volume":"386","author":"Carey","year":"2015","journal-title":"The Lancet"},{"key":"R4-20241015","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.autrev.2014.01.041","article-title":"The diagnosis of primary biliary cirrhosis","volume":"13","author":"Bowlus","year":"2014","journal-title":"Autoimmun Rev"},{"key":"R5-20241015","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jhep.2017.03.022","article-title":"EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis","volume":"67","author":"Hirschfield","year":"2017","journal-title":"J Hepatol"},{"key":"R6-20241015","article-title":"Primary biliary cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases","author":"Lindor","year":"2018","journal-title":"Hepatology"},{"key":"R7-20241015","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/hep.26365","article-title":"Impact of primary biliary cirrhosis on perceived quality of life: The UK-PBC national study","volume":"58","author":"Mells","year":"2013","journal-title":"Hepatology"},{"key":"R8-20241015","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/hep.23683","article-title":"The specificity of fatigue in primary biliary cirrhosis: Evaluation of a large clinic practice","volume":"52","author":"Al-Harthy","year":"2010","journal-title":"Hepatology"},{"key":"R9-20241015","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.jhep.2005.12.012","article-title":"Characterisation of the associations and impact of symptoms in primary biliary cirrhosis using a disease specific quality of life measure","volume":"44","author":"Newton","year":"2006","journal-title":"J Hepatol"},{"key":"R10-20241015","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1016\/S0140-6736(10)61965-4","article-title":"Primary biliary cirrhosis","volume":"377","author":"Selmi","year":"2011","journal-title":"Lancet"},{"key":"R11-20241015","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.4254\/wjh.v14.i6.1111","article-title":"Understanding fatigue in primary biliary cholangitis: From pathophysiology to treatment perspectives","volume":"14","author":"Lynch","year":"2022","journal-title":"World J Hepatol"},{"key":"R12-20241015","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1159\/000440757","article-title":"Fatigue in primary biliary cirrhosis: Prevalence, pathogenesis and management","volume":"33","author":"Jopson","year":"2015","journal-title":"Dig Dis"},{"key":"R13-20241015","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.cld.2022.06.009","article-title":"Evaluation and management of pruritus in primary biliary cholangitis","volume":"26","author":"D\u00fcll","year":"2022","journal-title":"Clin Liver Dis"},{"key":"R14-20241015","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s11901-020-00517-x","article-title":"Newer approaches to the management of pruritus in cholestatic liver disease","volume":"19","author":"D\u00fcll","year":"2020","journal-title":"Curr Hepatol Rep"},{"key":"R15-20241015","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/liv.12560","article-title":"Fatigue and pruritus at onset identify a more aggressive subset of primary biliary cirrhosis","volume":"35","author":"Quarneti","year":"2014","journal-title":"Liver International"},{"key":"R16-20241015","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.tins.2013.10.003","article-title":"The neuroimmune basis of fatigue","volume":"37","author":"Dantzer","year":"2014","journal-title":"Trends Neurosci"},{"key":"R17-20241015","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1523\/JNEUROSCI.3567-08.2009","article-title":"Cerebral microglia recruit monocytes into the brain in response to tumor necrosis factoralpha signaling during peripheral organ inflammation","volume":"29","author":"D\u2019Mello","year":"2009","journal-title":"J Neurosci"},{"key":"R18-20241015","doi-asserted-by":"crossref","first-page":"e107","DOI":"10.1038\/ctg.2017.34","article-title":"Primary biliary cholangitis alters functional connections of the brain\u2019s deep gray matter","volume":"8","author":"Mosher","year":"2017","journal-title":"Clin Transl Gastroenterol"},{"key":"R20-20241015","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.neuroimage.2009.12.109","article-title":"The role of the right inferior frontal gyrus: Inhibition and attentional control","volume":"50","author":"Hampshire","year":"2010","journal-title":"Neuroimage"},{"key":"R21-20241015","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1016\/j.neuropsychologia.2005.11.019","article-title":"Development of a superior frontal\u2013intraparietal network for visuo-spatial working memory","volume":"44","author":"Klingberg","year":"2006","journal-title":"Neuropsychologia"},{"key":"R22-20241015","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/hep.22371","article-title":"Cognitive impairment in primary biliary cirrhosis: Symptom impact and potential etiology","volume":"48","author":"Newton","year":"2008","journal-title":"Hepatology"},{"key":"R23-20241015","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jhep.2013.02.019","article-title":"The impact of liver transplantation on the phenotype of primary biliary cirrhosis patients in the UK-PBC cohort","volume":"59","author":"Pells","year":"2013","journal-title":"J Hepatol"},{"key":"R24-20241015","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.jhep.2010.05.036","article-title":"Central nervous system dysfunction in primary biliary cirrhosis and its relationship to symptoms","volume":"53","author":"McDonald","year":"2010","journal-title":"J Hepatol"},{"key":"R25-20241015","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.1365-2982.2007.01016.x","article-title":"Downregulated hypothalamic 5-HT3 receptor expression and enhanced 5-HT3 receptor antagonist-mediated improvement in fatigue-like behaviour in cholestatic rats","volume":"20","author":"Nguyen","year":"2008","journal-title":"Neurogastroenterol Motil"},{"key":"R26-20241015","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1001\/jama.285.17.2196","article-title":"Grip strength and subjective fatigue in patients with primary biliary cirrhosis","volume":"285","author":"Goldblatt","year":"2001","journal-title":"JAMA"},{"key":"R27-20241015","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.cgh.2008.04.013","article-title":"Pilot study of peripheral muscle function in primary biliary cirrhosis: Potential implications for fatigue pathogenesis","volume":"6","author":"Hollingsworth","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R28-20241015","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.jhep.2007.01.036","article-title":"Depression in patients with primary biliary cirrhosis and primary sclerosing cholangitis","volume":"46","author":"van Os","year":"2007","journal-title":"J Hepatol"},{"key":"R29-20241015","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/hep.21230","article-title":"Fatigue in primary biliary cirrhosis is associated with excessive daytime somnolence","volume":"44","author":"Newton","year":"2006","journal-title":"Hepatology"},{"key":"R30-20241015","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1111\/ijd.15341","article-title":"Measuring fatigue: A meta\u2010review","volume":"60","author":"Machado","year":"2020","journal-title":"Int J Dermatol"},{"key":"R31-20241015","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/NNR.0000000000000162","article-title":"Psychometric evaluation of the patient-reported outcomes measurement information system fatigue-short form across diverse populations","volume":"65","author":"Ameringer","year":"2016","journal-title":"Nurs Res"},{"key":"R32-20241015","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.jclinepi.2010.04.011","article-title":"The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005\u20132008","volume":"63","author":"Cella","year":"2010","journal-title":"J Clin Epidemiol"},{"key":"R33-20241015","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1136\/gut.2005.065862","article-title":"Development, validation, and evaluation of the PBC-40, a disease specific health related quality of life measure for primary biliary cirrhosis","volume":"54","author":"Jacoby","year":"2005","journal-title":"Gut"},{"key":"R34-20241015","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/sleep\/14.6.540","article-title":"A new method for measuring daytime sleepiness: The Epworth Sleepiness Scale","volume":"14","author":"Johns","year":"1991","journal-title":"Sleep"},{"key":"R35-20241015","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/01.meg.0000252629.96043.67","article-title":"Autonomic dysfunction in primary biliary cirrhosis correlates with fatigue severity","volume":"19","author":"Newton","year":"2007","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R36-20241015","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s10286-020-00738-6","article-title":"Recommendations for tilt table testing and other provocative cardiovascular autonomic tests in conditions that may cause transient loss of consciousness","volume":"31","author":"Thijs","year":"2021","journal-title":"Clin Auton Res"},{"key":"R37-20241015","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1053\/j.gastro.2014.12.005","article-title":"Efficacy of obeticholic acid in patients with primary biliary cirrhosis and inadequate response to ursodeoxycholic acid","volume":"148","author":"Hirschfield","year":"2015","journal-title":"Gastroenterology"},{"key":"R38-20241015","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1056\/NEJMoa1714519","article-title":"A placebo-controlled trial of bezafibrate in primary biliary cholangitis","volume":"378","author":"Corpechot","year":"2018","journal-title":"N Engl J Med"},{"key":"R39-20241015","doi-asserted-by":"crossref","first-page":"e167","DOI":"10.1097\/MJT.0000000000000387","article-title":"A randomized, placebo-controlled clinical trial of efficacy and safety","volume":"24","author":"Silveira","year":"2017","journal-title":"Am J Ther"},{"key":"R40-20241015","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.3389\/fphys.2018.01530","article-title":"Morning bright light treatment for sleep-wake disturbances in primary biliary cholangitis: A pilot study","volume":"9","author":"Turco","year":"2018","journal-title":"Front Physiol"},{"key":"R41-20241015","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/liv.12035","article-title":"Restless leg syndrome is a treatable cause of sleep disturbance and fatigue in primary biliary cirrhosis","volume":"33","author":"Anderson","year":"2013","journal-title":"Liver Int"},{"key":"R42-20241015","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jhep.2010.02.022","article-title":"Loss of capacity to recover from acidosis in repeat exercise is strongly associated with fatigue in primary biliary cirrhosis","volume":"53","author":"Hollingsworth","year":"2010","journal-title":"J Hepatol"},{"key":"R43-20241015","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/liv.15039","article-title":"Seladelpar improved measures of pruritus, sleep, and fatigue and decreased serum bile acids in patients with primary biliary cholangitis","volume":"42","author":"Kremer","year":"2022","journal-title":"Liver Int"},{"key":"R44-20241015","doi-asserted-by":"crossref","first-page":"273","DOI":"10.15403\/jgld.2014.1121.273.icz","article-title":"Effect of S-adenosyl-L-methionine on liver biochemistry and quality of lLife in patients with primary biliary cholangitis treated with ursodeoxycholic acid. A prospective, open label pilot study","volume":"27","author":"Wunsch","year":"2018","journal-title":"J Gastrointestin Liver Dis"},{"key":"R45-20241015","first-page":"205","article-title":"Plasmapheresis in the treatment of chronic fatigue in patients with primary biliary cholangitis","volume":"131","author":"Wunsch","year":"2021","journal-title":"Polish Archives of Internal Medicine"},{"key":"R46-20241015","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/ajg.2013.51","article-title":"B-cell depletion with rituximab in patients with primary biliary cirrhosis refractory to ursodeoxycholic acid","volume":"108","author":"Myers","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"R47-20241015","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1136\/gut.2003.023937","article-title":"Asymptomatic primary biliary cirrhosis: Clinical features, prognosis, and symptom progression in a large population based cohort","volume":"53","author":"Prince","year":"2004","journal-title":"Gut"},{"key":"R48-20241015","doi-asserted-by":"crossref","first-page":"34","DOI":"10.2340\/00015555-0350","article-title":"Itch in primary biliary cirrhosis: A patients\u2019 perspective","volume":"88","author":"Rishe","year":"2008","journal-title":"Acta Derm Venereol"},{"key":"R49-20241015","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1136\/flgastro-2015-100618","article-title":"A systematic approach to the management of cholestatic pruritus in primary biliary cirrhosis","volume":"7","author":"Hegade","year":"2016","journal-title":"Frontline Gastroenterol"},{"key":"R50-20241015","doi-asserted-by":"crossref","first-page":"639674","DOI":"10.3389\/fmed.2021.639674","article-title":"Cholestasis-associated pruritus and its pruritogens","volume":"8","author":"Langedijk","year":"2021","journal-title":"Front Med"},{"key":"R51-20241015","doi-asserted-by":"crossref","first-page":"e48431","DOI":"10.7554\/eLife.48431","article-title":"MRGPRX4 is a bile acid receptor for human cholestatic itch","volume":"8","author":"Yu","year":"2019","journal-title":"eLife"},{"key":"R52-20241015","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1053\/j.gastro.2014.08.042","article-title":"The bile acid receptor TGR5 activates the TRPA1 channel to induce itch in mice","volume":"147","author":"Lieu","year":"2014","journal-title":"Gastroenterology"},{"key":"R53-20241015","first-page":"1008","article-title":"Lysophosphatidic acid is a potential mediator of cholestatic pruritus","volume":"139","author":"Kremer","year":"2010"},{"key":"R54-20241015","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/j.ajpath.2014.01.029","article-title":"Potentials of the circulating pruritogenic mediator lysophosphatidic acid in development of allergic skin inflammation in mice","volume":"184","author":"Shimizu","year":"2014","journal-title":"Am J Pathol"},{"key":"R55-20241015","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1002\/hep.25748","article-title":"Serum autotaxin is increased in pruritus of cholestasis, but not of other origin, and responds to therapeutic interventions","volume":"56","author":"Kremer","year":"2012","journal-title":"Hepatology"},{"key":"R56-20241015","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1600-0676.1996.tb00749.x","article-title":"Hepatic concentrations of proenkephalin-derived opioids are increased in a rat model of cholestasis","volume":"16","author":"Bergasa","year":"2008","journal-title":"Liver"},{"key":"R57-20241015","first-page":"24","article-title":"Management of cholestatic pruritus in primary biliary cholangitis: Ileal bile acid transporter inhibition and holistic care","volume":"11","author":"Jones","year":"2023","journal-title":"EMJ Hepatol Hepatology"},{"key":"R58-20241015","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/lt.20001","article-title":"Treatment of refractory cholestatic pruritus after liver transplantation with albumin dialysis","volume":"10","author":"Bellmann","year":"2004","journal-title":"Liver Transpl"},{"key":"R59-20241015","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/S0140-6736(17)30319-7","article-title":"Effect of ileal bile acid transporter inhibitor GSK2330672 on pruritus in primary biliary cholangitis: A double-blind, randomised, placebo-controlled, crossover, phase 2a study","volume":"389","author":"Hegade","year":"2017","journal-title":"Lancet (London, England)"},{"key":"R60-20241015","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.cld.2022.06.013","article-title":"Novel therapies in primary biliary cholangitis","volume":"26","author":"Buchanan-Peart","year":"2022","journal-title":"Clin Liver Dis"},{"key":"R61-20241015","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1053\/j.gastro.2020.10.001","article-title":"Fibrates for itch (FITCH) in fibrosing cholangiopathies: A double-blind, randomized, placebo-controlled trial","volume":"160","author":"de Vries","year":"2021","journal-title":"Gastroenterology"}],"container-title":["Clinical Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CLD.0000000000000216","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T22:12:02Z","timestamp":1729030322000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CLD.0000000000000216"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/cld.0000000000000216","relation":{},"ISSN":["2046-2484"],"issn-type":[{"value":"2046-2484","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"2024-01-04","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-04-08","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}